Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …

J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …

Therapeutic plasma exchange in myasthenia gravis: a systematic literature review and meta-analysis of comparative evidence

TS Ipe, AR Davis, JS Raval - Frontiers in Neurology, 2021 - frontiersin.org
Background: Patients with Myasthenia Gravis (MG) can be treated acutely with therapeutic
plasma exchange (TPE) or intravenous immune globulin (IVIG). To date, there is no …

Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

J Schwartz, JL Winters, A Padmanabhan… - Journal of clinical …, 2013 - Wiley Online Library
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is
charged with reviewing, updating and categorizating indications for therapeutic apheresis …

Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Apheresis Applications Committee of the American Society for …

ZM Szczepiorkowski, JL Winters… - Journal of clinical …, 2010 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Apheresis Applications Committee is
charged with a review and categorization of indications for therapeutic apheresis. Beginning …

[PDF][PDF] Эфферентная терапия. Мембранный плазмаферез

ВА Воинов - СПб.: Эскулап, 2002 - trackpore.ru
После четвёртого издания этой книги мембранные плазмофильтры и аппаратура
продолжали совершенствоваться, и возникла необходимость пятого издания, которое …

Comparative analysis of therapeutic options used for myasthenia gravis

A Mandawat, HJ Kaminski, G Cutter, B Katirji… - Annals of …, 2010 - Wiley Online Library
Objective To compare clinical and economic outcomes following plasma exchange (PLEX)
and intravenous immunoglobulin (IVIG) in US patients with primary diagnoses of myasthenia …

[HTML][HTML] Comparative clinical outcomes after thymectomy for myasthenia gravis: Thoracoscopic versus trans-sternal approach

S Siwachat, A Tantraworasin, W Lapisatepun… - Asian journal of …, 2018 - Elsevier
Background Thymectomy is an effective treatment option for long-term remission of
myasthenia gravis. The superiority of the trans-sternal and thoracoscopic surgical …

Therapeutic plasma exchange–a brief review of indications, urgency, schedule, and technical aspects

HP Pham, EM Staley, J Schwartz - Transfusion and Apheresis Science, 2019 - Elsevier
Abstract The American Society for Apheresis (ASFA) regularly publishes evidence-based
guidelines, with the most recent edition in 2016, to assist the requesting and/or apheresis …

Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis

J Gamez, M Salvadó, F Carmona… - Therapeutic …, 2019 - journals.sagepub.com
Background: Myasthenic crisis (MC) is a potentially life-threatening complication of
myasthenia gravis. Its precipitating factors include surgical procedures, particularly …

Outcome of plasmapheresis in myasthenia gravis: delayed therapy is not favorable

A Mandawat, A Mandawat, HJ Kaminski… - Muscle & …, 2011 - Wiley Online Library
Introduction: The purpose of this study was to compare the in‐hospital mortality and
complication rates after early and delayed initiation of plasma exchange (PLEX) in patients …